I disagree with Dkonara921 on one aspect. I agree with the fact that regulations are made with good intentions, and that companies can work around them. I disagree with the notion that the FDA should allow drugs that don’t work. Maybe you mean “drugs that don’t work effectively, but still somewhat work”. What’s the point of marketing a drug that doesn’t work? It’s pointless. Why pay for a product, even a cheap product, that doesn’t work? Quality matters, but pricing in accordance with quality could be a possibility for those who can’t afford the best drugs but can get by on lower quality drugs.